Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.
Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: A combined optical coherence tomography and diffusion tensor imaging study.
Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.
Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis.
Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study.
Sleep Loss as a Factor to Induce Cellular and Molecular Inflammatory Variations.
Multiple sclerosis: IL-12p40-an early biomarker for multiple sclerosis?
The role of cytomegalovirus, haemophilus influenzae and epstein barr virus in guillain barre syndrome.
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
A Two Sample Distribution-Free Test for Functional Data with Application to a Diffusion Tensor Imaging Study of Multiple Sclerosis.
Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance.
New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset.
Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS.
Smoking worsens multiple sclerosis prognosis: Two different pathways are involved.
Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
Office immunotherapy in chronic inflammatoryh demyelinating polyneuropathy and multifocal motor neuropathy.
The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.
Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients.
Bilateral optic neuritis associated with scrub typhus.
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke.
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »